Adq. Anual Farmacos 2
El Instituto Nacional del Cáncer requiere contratar el suministro de los Fármacos 2 necesarios para el óptimo funcionamiento de los servicios clínicos.
19 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 359-3835-SE15 | 31-12-2015 | Pfizer Chile S.A. | $195.160 |
| 359-3840-SE15 | 31-12-2015 | Winpharm SpA | $357.000 |
| 359-3839-SE15 | 31-12-2015 | Laboratorio Sanderson S.A. | $38.913 |
| 359-3837-SE15 | 31-12-2015 | Megalabs Chile S.A. | $23.800 |
| 359-3553-SE15 | 04-12-2015 | Laboratorio Sanderson S.A. | $103.768 |
| 359-3552-SE15 | 04-12-2015 | Megalabs Chile S.A. | $91.035 |
| 359-3551-SE15 | 04-12-2015 | Pfizer Chile S.A. | $5.671.540 |
| 359-3550-SE15 | 04-12-2015 | Inversiones Pmg S.A. | $270.666 |
| 359-3549-SE15 | 04-12-2015 | Grunenthal Chilena Limitada | $737.800 |
| 359-3548-SE15 | 04-12-2015 | Fresenius Kabi Chile Limitada | $456.960 |
| 359-3547-SE15 | 04-12-2015 | Ethon Pharmaceuticals Ltda. | $54.740 |
| 359-3545-SE15 | 04-12-2015 | Industrial y Comercial Baxter de Chile Limitada | $4.430.370 |
| 359-3546-SE15 | 04-12-2015 | Bayer S.A. | $588.860 |
| 359-3558-SE15 | 04-12-2015 | Winpharm SpA | $896.070 |
| 359-3556-SE15 | 04-12-2015 | Synthon Chile Limitada | $93.534 |
| 359-3554-SE15 | 04-12-2015 | Aventis Pharma Holding Gmbh | $3.713 |
| 359-3189-SE15 | 11-11-2015 | Ethon Pharmaceuticals Ltda. | $136.850 |
| 359-3187-SE15 | 11-11-2015 | Industrial y Comercial Baxter de Chile Limitada | $809.200 |
| 359-3188-SE15 | 11-11-2015 | Bayer S.A. | $142.610 |
| 359-3190-SE15 | 11-11-2015 | Fresenius Kabi Chile Limitada | $342.720 |
| 359-3191-SE15 | 11-11-2015 | Grunenthal Chilena Limitada | $442.680 |
| 359-3192-SE15 | 11-11-2015 | Inversiones Pmg S.A. | $26.775 |
| 359-3193-SE15 | 11-11-2015 | Pfizer Chile S.A. | $2.525.180 |
| 359-3194-SE15 | 11-11-2015 | Laboratorio Sanderson S.A. | $18.445 |
| 359-3195-SE15 | 11-11-2015 | Synthon Chile Limitada | $23.086 |
| 359-3196-SE15 | 11-11-2015 | Winpharm SpA | $892.500 |
| 359-2743-SE15 | 01-10-2015 | Inversiones Pmg S.A. | $273.581 |
| 359-2739-SE15 | 01-10-2015 | Bayer S.A. | $71.305 |
| 359-2738-SE15 | 01-10-2015 | Industrial y Comercial Baxter de Chile Limitada | $2.427.600 |
| 359-2747-SE15 | 01-10-2015 | Winpharm SpA | $357.000 |
| 359-2746-SE15 | 01-10-2015 | Synthon Chile Limitada | $10.710 |
| 359-2745-SE15 | 01-10-2015 | Laboratorio Sanderson S.A. | $33.915 |
| 359-2744-SE15 | 01-10-2015 | Pfizer Chile S.A. | $476.000 |
| 359-2351-SE15 | 29-08-2015 | Aventis Pharma Holding Gmbh | $4.641 |
| 359-2348-SE15 | 29-08-2015 | Pfizer Chile S.A. | $2.134.860 |
| 359-2347-SE15 | 29-08-2015 | Inversiones Pmg S.A. | $44.625 |
| 359-2346-SE15 | 29-08-2015 | Bayer S.A. | $294.430 |
| 359-2345-SE15 | 29-08-2015 | Industrial y Comercial Baxter de Chile Limitada | $2.427.600 |
| 359-1773-SE15 | 29-08-2015 | Megalabs Chile S.A. | $41.650 |
| 359-2353-SE15 | 29-08-2015 | Winpharm SpA | $634.270 |
| 359-2352-SE15 | 29-08-2015 | Synthon Chile Limitada | $10.710 |
| 359-2349-SE15 | 29-08-2015 | Laboratorio Sanderson S.A. | $71.876 |
| 359-2096-SE15 | 07-08-2015 | Winpharm SpA | $24.990 |
| 359-2090-SE15 | 07-08-2015 | Industrial y Comercial Baxter de Chile Limitada | $2.023.000 |
| 359-1774-SE15 | 07-08-2015 | Ethon Pharmaceuticals Ltda. | $27.370 |
| 359-1775-SE15 | 07-08-2015 | Aventis Pharma Holding Gmbh | $7.890 |
| 359-1782-SE15 | 07-08-2015 | Synthon Chile Limitada | $16.898 |
| 359-2091-SE15 | 07-08-2015 | Bayer S.A. | $829.930 |
| 359-2093-SE15 | 07-08-2015 | Pfizer Chile S.A. | $1.447.040 |
| 359-2095-SE15 | 07-08-2015 | Laboratorio Sanderson S.A. | $199.444 |
| 359-1864-SE15 | 23-07-2015 | Laboratorio Sanderson S.A. | $136.374 |
| 359-1771-SE15 | 23-07-2015 | Inversiones Pmg S.A. | $89.250 |
| 359-1777-SE15 | 23-07-2015 | Bayer S.A. | $35.652 |
| 359-1780-SE15 | 23-07-2015 | Industrial y Comercial Baxter de Chile Limitada | $606.900 |
| 359-1781-SE15 | 23-07-2015 | Winpharm SpA | $191.590 |
| 359-1784-SE15 | 15-07-2015 | Pfizer Chile S.A. | $4.088.840 |
Fuente original:ficha mercadopublico.cl
